Kezar Life Sciences has become the latest biotech to decide that it could do better than a buyout offer from Concentra Biosciences. Concentra’s parent company Tang Capital Partners has a track ...

(RTTNews) - Kezar Life Sciences (KZR) announced that its Board has rejected the unsolicited, non-binding proposal from Concentra Biosciences, to acquire all of the outstanding shares of common ...

The proposal, revealed in a Schedule 13D filing with the U.S. Securities and Exchange Commission on October 8, 2024, indicates that Tang Capital Management, LLC, the majority owner of Concentra ...

Concentra Group Holdings Parent, Inc. (NYSE:CON), the largest provider of occupational health services in the United States, has recently attracted attention from Wall Street analysts. The company ...

Earlier on Thursday, Kezar Life Sciences rejected the previously disclosed unsolicited, non-binding proposal from Concentra Biosciences for cash consideration of $1.10 per share, plus a contingent ...

Looking to capitalize on this momentum, Dogizen has announced the first ever Telegram-based ICO. Dogizen is now ideally placed to convert its gaming audience into a thriving investor community for ...

Ethereum, Filecoin, Chainlink, and many other billion-dollar cryptocurrencies raised funds via ICO campaigns, so this investment niche can be lucrative. So, let’s get acquainted with the top ...

Apart from reviewing some of the top ICO cryptos currently in existence, we’ll also examine some upcoming ICOs and tackle the inherent risks and rewards of such early-stage investments.

UK data protection regulator the Information Commissioner's Office (ICO) has launched an investigation into MoneyGram International, the world's second-largest money transfer provider, following a ...